Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-13-006700)

Filing Details

Accession Number:: 0001104659-13-006700
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-02-01 10:06:38
Reporting Period:: 2013-01-30

Filing Date:: 2013-02-01
Accepted Time:: 2013-02-01 10:06:38
Original Submission Date:: 2013-01-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1347613	Synergy Pharmaceuticals Inc.	SGYP	Pharmaceutical Preparations (2834)	330505269

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253803	Gabriel Cerrone	C/O Synergy Pharmaceuticals Inc. 420 Lexington Avenue, Suite 1609 New York NY 10170	Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-30	6,000	$5.97	842,783	No	4	P	Indirect	By Panetta Partners, Ltd.
Common Stock	Acquisiton	2013-01-30	20,000	$5.99	862,783	No	4	P	Indirect	By Panetta Partners, Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Panetta Partners, Ltd.
No	4	P	Indirect	By Panetta Partners, Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	187,470	Direct

Footnotes

Mr. Cerrone is the sole director of Panetta Partners Ltd. and in such capacity exercise voting and dispositive control over securities owned by Panetta Partners Ltd. despite him having only a small pecuniary interest in such securities.